Immorna Biotherapeutics
PrivateLast Round
Grant
Aug 26, 2024
Total Funding Raised
$118.8M
Company Overview
Immorna Biotherapeutics is a biotechnology company that develops RNA-based therapeutics and vaccines for infectious diseases, cancer, and autoimmune diseases.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immorna Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Immorna Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 26, 2024 | ||||
| Series A Extension | Feb 27, 2023 | ||||
| Series A | Feb 1, 2021 |
Immorna Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Pre Seed |
| Zheshang Venture Capital | Series A Extension, Series A |
| Hillhouse Investment | Series A Extension |
| Co-Win Ventures | Series A Extension, Series A |
| Tailong Investment | Series A Extension |
| GL Ventures | Series A Extension |
| Tigeryeah Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2024
$3.8M grant from the Bill & Melinda Gates Foundation.
- Feb 27, 2023
$100M round with participation from China Structural Reform Fund and Hillhouse Investment.
Immorna Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immorna Biotherapeutics's valuation, stock price, and market status.
